12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Monday's after-market session. TransCode Therapeutics, Shuttle Pharmaceuticals, Artelo Biosciences, Catalyst Biosciences, Renalytix, and Vivani Medical saw increases in their share prices, while Orgenesis, GeneDx Hldgs, Catalent, Sientra, Regenxbio, and Akari Therapeutics saw decreases.
October 30, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Artelo Biosciences shares increased by 12.69% to $1.42.
The significant increase in share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Catalyst Biosciences stock moved upwards by 7.7% to $0.55.
The significant increase in share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
TransCode Therapeutics shares increased by 16.7% to $0.42.
The significant increase in share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Renalytix stock moved upwards by 7.61% to $1.13.
The significant increase in share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Shuttle Pharmaceuticals shares rose 16.23% to $0.54.
The significant increase in share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Vivani Medical shares moved upwards by 6.48% to $1.15.
The significant increase in share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Akari Therapeutics shares decreased by 9.17% to $3.27.
The significant decrease in share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Catalent shares fell 14.83% to $34.0.
The significant decrease in share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Orgenesis stock declined by 32.1% to $0.55.
The significant decrease in share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Regenxbio shares decreased by 13.02% to $12.5.
The significant decrease in share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Sientra shares decreased by 14.39% to $1.25.
The significant decrease in share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
GeneDx Hldgs shares decreased by 16.11% to $2.24.
The significant decrease in share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100